Omnicell Inc. (OMCL)
-NasdaqGS 18.20 
0.23(1.25%) 4:00PM EDT|After Hours
:
18.26 0.06 (0.34%) 4:35PM EDT
| Prev Close: | 18.43 |
|---|
| Open: | 18.31 |
|---|
| Bid: | 8.40 x 100 |
|---|
| Ask: | 22.42 x 100 |
|---|
| 1y Target Est: | 21.50 |
|---|
| Beta: | 0.97 |
|---|
| Next Earnings Date: | 2-Aug-13 |
|---|
| Day's Range: | 18.10 - 18.48 |
|---|
| 52wk Range: | 12.33 - 20.00 |
|---|
| Volume: | 156,009 |
|---|
| Avg Vol (3m): | 163,370 |
|---|
| Market Cap: | 624.82M |
|---|
| P/E (ttm): | 36.40 |
|---|
| EPS (ttm): | 0.50 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 2 Services Companies And 1 Tech Stock With Recent Intensive Insider Sellingat Seeking Alpha(Wed, May 15)
- OMNICELL, INC FinancialsEDGAR Online Financials(Wed, May 15)
- Omnicell To Present At The 14th Annual B. Riley & Co. Investor ConferencePR Newswire(Tue, May 14)
- [$$] What to Make of ExxonMobil and Whole Foods?at Barrons.com(Thu, May 9)
- OMNICELL, INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 8)
- 4 Small Caps That Still Have Biteat Forbes(Wed, May 8)
- Covance Beats Earnings, Rev, Ups ViewZacks(Mon, May 6)
- 5 Healthcare Stocks Heading in Different Directions After Earningsat Wall St. Cheat Sheet(Sat, May 4)
- Dismal Earnings Miss by OmnicellZacks(Fri, May 3)
- Omnicell Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 2)
- Omnicell Earnings: Here’s Why Investors are Not Happy Nowat Wall St. Cheat Sheet(Thu, May 2)
- Omnicell Announces First Quarter 2013 ResultsPR Newswire(Thu, May 2)
- OMNICELL, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Thu, May 2)
- Q1 2013 Omnicell, Inc. Earnings Release - Time Not SuppliedCCBN(Thu, May 2)
- Vanguard Health Systems to Implement Omnicell G4 Unity Platform SystemwidePR Newswire(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 15.17 |
|---|
| P/S (ttm): | 1.88 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.04 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.25 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 1.20 |
|---|
Business Summary
Omnicell, Inc. provides automated solutions for medication and supply management in healthcare in the United States and internationally. The company operates in two segments, Acute Care and Non-Acute Care.
View More